Dobrokachestvennye giperplazii matki i vnutrimatochnaya levonorgestrel-rilizing sistema
- Authors: Tikhomirov AL1, Ledenkova AA1
-
Affiliations:
- Issue: Vol 14, No 3 (2012)
- Pages: 62-64
- Section: Articles
- URL: https://gynecology.orscience.ru/2079-5831/article/view/33321
Cite item
Full Text
Abstract
References
- Вихляева Е.М. О стратегии и тактике ведения больных с миомой матки. Вестн. рос. ассоц. акушеров-гинекологов. 1997; 3: 21-3.
- Сидорова И.С. Миома матки. М.: Медицинское информационное агентство, 2005.
- Тихомиров А.Л., Залеева Е.В. Роль левоноргестрел-рилизинг системы в комплексном лечении миомы матки. Актуальные вопросы клинической транспортной медицины, 2006.
- Тихомиров А.Л., Лубнин Д.М. Контрацепция у больных миомой матки. Рус. мед. журн. 2002; 10 (4): 212-15.
- Тихомиров А.Л., Лубнин Д.М. Миома матки. М.: Медицинское информационное агентство, 2006.
- Тихомиров А.Л., Лубнин Д.М. Новый принцип лечения миомы матки. Методическое руководство для врачей акушеров-гинекологов. М., 2006.
- Тихомиров А.Л., Тускаев К.С., Залеева Е.В. Применение внутриматочной гормональной рилизинг-системы в комплексном органосохраняющем лечении миомы матки. Методическое руководство для врачей акушеров-гинекологов. М., 2005.
- Bahamondes, Ribeiro-Huguet. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand 2003; 82 (6): 580-2.
- Baldaszti E, Wimmer-Puchinger B. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception 2003; 67 (2): 87-91.
- Fedele L, Bianchi S, Raffaelli R et al. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997; 68: 426-29.
- Fedele L, Bianchi S, Zanconato G et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of recto- vaginal endometriosis. Fertil Steril 2001; 75: 485-88.
- French RS, Cowan FM, Mansour D et al. Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. Bjog 2000; 107 (10): 1218-25.
- Giannopoulos T, Butler-Manuel S et al. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol 2004; 95 (3): 762-4.
- Laoag-Fernandez JB, Maruo T et al. Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. Hum Reprod 2003; 18 (4): 694-9.
- Levy BS. Management of uterine fibroids. Acta Obstet Gynecol Scand 2008; 87 (8): 812-23.
- Maia H, Maltez A. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003; 10 (4): 512-6.
- Perino A, Quartararo P, Catinella E et al. Тreatment of endometrial hyperplasis with levonorgestrel-releasing intrauterine devices. Acta Fertil 1987.
- Rachev E. Mirena - the first intrauterine contraceptive rherapeutic system. Akush Ginekol (Sofiia) 2001; 40 (Suppl. 6): 3-6.
- Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ. Health Perspect 2000; 108 (5): 791-3.
- Searselli G, Tantini C, Colafranceschi M et al. Levonorgestrel-releasing intrauterine devices and precancerous lesious of the endometrium. Eur J Gynaecol Oncol 1988; 9 (4): 284-86.
- Tiltman AJ. Smooth muscle neoplasms of the uterus. Curr Opin Obstet Gynecol 1997; 9 (1): 48-51.
- Vercellini P, Aimi G, Panazza S et al. A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72 (3): 505-8.
- Vollenboven BJ, Lawrence AS, Healy DL. Uterine fibroids 1997; 97: 285-98.
- Wang S, Su Q. Clonality of multiple uterine leiomyomas. Zhonghua Bing Li Xue Za Zhi 2002; 31 (2): 107-11.
